Alzheimer's & Dementia
Clinical utility of LUMIPULSE plasma p-tau217 to identify amyloid positivity among candidates for amyloid-targeting treatments in a real-world cohort
Cohort study of 99 peopleBiomarkers
The paper
Tokyo Metropolitan Institute of Gerontology
Alzheimer's & Dementia, 1 Jul 2026, CC BY-NC
